NCT01437124

Brief Summary

The investigators aim to measure the blood levels of certain metals in a group of patients all of whom have had a ceramic on metal total hip replacement. This new bearing surface (joint) is relatively new and the investigators are currently following up the largest cohort in the world. Clinical results are currently excellent at 2 years in all patients, however the investigators are mindful of the lessons learned from the high failure rate of several designs of metal on metal hip replacements as well as several in vitro reports and one in vivo case report of elevated metal levels in this particular implant. The investigators feel it is important to measure the metal ion levels in our group to ascertain and compare these with reference standards. Once performed the investigators can relate ion levels to function and x ray changes and provide useful longterm data to the patients and the wider medical community as to whether this bearing surface is safe in the long term or whether it's use should be abandoned. This is useful as there are numerous groups implanting this device in the UK and in addition it has just been awarded FDA approval in the USA - its use is likely to flourish.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 20, 2011

Completed
11 days until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
4.1 years until next milestone

Results Posted

Study results publicly available

June 6, 2016

Completed
Last Updated

June 6, 2016

Status Verified

April 1, 2016

Enrollment Period

7 months

First QC Date

September 16, 2011

Results QC Date

April 27, 2016

Last Update Submit

April 27, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cobalt Chromium Levels

    Serum cobalt chromium levels post THR

    2 years post THR

Secondary Outcomes (1)

  • Chromosomal Abnormality

    2 years post THR

Study Arms (1)

Ceramic on metal THA

Those who have received a ceramic on metal total hip replacement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Those who have received a ceramic on metal total hip arthroplasty

You may qualify if:

  • Over 18 years of age
  • Complete history and physical examination
  • Previously performed ceramic on metal total hip replacement
  • An understanding of the purpose of the study and signed consent form

You may not qualify if:

  • Hip arthroplasty other than ceramic on metal bearing
  • Mentally infirm / incapacitated
  • Incomplete history or physical examination
  • Unwillingness to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wirral University Teaching Hospitals NHS Foundation Trust

Metropolitan Borough of Wirral, Merseyside, CH49 5PE, United Kingdom

Location

MeSH Terms

Conditions

OsteoarthritisOsteonecrosisArthritis, RheumatoidDevelopmental Dysplasia of the Hip

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesHip DislocationJoint DislocationsMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Hussain Kazi
Organization
Wirral NHS Trust

Study Officials

  • Fintan A Carroll, MBBS, FRCS

    Consultant Orthopaedic Surgeon

    STUDY DIRECTOR
  • Hussain A Kazi, MBChB,FRCS

    Specialist Registrar, Trauma & Orthopaedics

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist Registrar, Trauma and Orthopaedics

Study Record Dates

First Submitted

September 16, 2011

First Posted

September 20, 2011

Study Start

October 1, 2011

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

June 6, 2016

Results First Posted

June 6, 2016

Record last verified: 2016-04

Locations